Traci van Gorden
Family · Sturgis, MINPI 1679513451
Payments from drug & device makers
Across 63 payments — averaging $17.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$223
- Amgen$184
- Lilly USA, LLC$92
- Biohaven Pharmaceuticals, Inc.$81
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$60
- Corcept Therapeutics$54
- plus $386 from 15 others
What the payments were for
- Food & beverage$1,080100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 14 | $223 |
| Amgen | 8 | $184 |
| Lilly USA, LLC | 6 | $92 |
| Biohaven Pharmaceuticals, Inc. | 4 | $81 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $60 |
| Corcept Therapeutics | 3 | $54 |
| Amarin Pharma, Inc. | 3 | $52 |
| Boehringer Ingelheim | 3 | $44 |
| AstraZeneca | 3 | $43 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $42 |
| AbbVie | 2 | $31 |
| Merck | 2 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $30 |
| Upsher-smith Laboratories LLC | 1 | $20 |
| Novartis | 1 | $19 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Eisai Inc. | 1 | $13 |
| Bayer | 1 | $12 |
| Nestle Healthcare Nutrition Inc. | 1 | $12 |
| Therapeuticsmd, Inc. | 1 | $12 |
| Radius Health, Inc. | 1 | $11 |
How this compares
$1,080 in reported general payments places this provider in the 70th percentile of 3,657 family providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 13 | $164 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 17 | $114 |
| Amoxicillin | 19 | $72 |
| Prednisone | 36 | $55 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $46 |
Paid to pharmacies, not to this prescriber.
Other family in Sturgis
- Jade KlinglerSturgis$10K
- Jayme HeimGrandville$663K
- Susan WolgamottBloomfield Township$327K
- Elisheva EllenbergDetroit$150K
- Sarah JohnsonFarmington Hills$119K
- Daniela MaximTroy$112K
- Kelsey PrinceGrand Rapids$87K
- Brent MillerFremont$66K
- Rachael CompeauFlint$62K
- David KocendaLapeer$49K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.